- Moneycontrol /
- Market /
- Pharmaceuticals /
- HALF YEARLY RESULTS
BSE Live
Aug 07, 09:38Prev. Close
35.15
Open Price
35.85
Bid Price (Qty.)
35.85 (867554)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Half Yearly Results of Bharat Immunologicals and Biologicals Corporation (in Rs. Cr.) | Sep '19 | Mar '19 | Sep '18 | Mar '18 | Sep '17 | |
| Net Sales/Income from operations | 15.10 | 78.89 | 4.76 | 26.15 | 8.65 | |
| Other Operating Income | -- | -- | -- | -- | -- | |
| Total Income From Operations | 15.10 | 78.89 | 4.76 | 26.15 | 8.65 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 47.77 | 68.62 | 18.01 | 18.45 | 11.46 | |
| Purchase of Traded Goods | -- | -- | -- | -- | -- | |
| Increase/Decrease in Stocks | -30.49 | 3.12 | -16.46 | 4.53 | -4.53 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 5.11 | 4.85 | 4.52 | 5.54 | 4.48 | |
| Depreciation | 0.26 | 0.07 | 0.21 | 0.13 | 0.29 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 5.15 | 6.17 | 3.74 | 1.71 | 1.64 | |
| P/L Before Other | -12.69 | -3.94 | -5.26 | -4.21 | -4.69 | |
| Other Income | 2.02 | 2.19 | 0.44 | 0.98 | 0.54 | |
| P/L Before Int. | -10.67 | -1.75 | -4.82 | -3.23 | -4.15 | |
| Interest | 2.15 | 1.37 | 0.13 | 0.49 | 0.03 | |
| P/L Before Exceptional Items & Tax | -12.82 | -3.11 | -4.94 | -3.72 | -4.18 | |
| Exceptional Items | -- | -- | -- | -- | -- | |
| P/L Before Tax | -12.82 | -3.11 | -4.94 | -3.72 | -4.18 | |
| Tax | -1.19 | -0.89 | -1.61 | -2.91 | 0.18 | |
| P/L After Tax from Ordinary Activities | -11.63 | -2.22 | -3.33 | -0.81 | -4.37 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | -11.63 | -2.22 | -3.33 | -0.81 | -4.37 | |
| Equity Share Capital | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | -2.66 | -- | -0.87 | -- | -1.01 | |
| Diluted EPS | -2.66 | -- | -0.87 | -- | -1.01 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | -2.66 | -- | -0.87 | -- | -1.01 | |
| Diluted EPS. | -2.66 | -- | -0.87 | -- | -1.01 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | 1.76 | |
| Share Holding (%) | -- | -- | -- | -- | 40.75 | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | 2.56 | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | 100.00 | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | 59.25 |
01.11.2019
Bharat Immuno Standalone September 2019 Net Sales at Rs 8.10 crore, up 73.39% Y-o-Y
02.08.2019
Bharat Immuno Standalone June 2019 Net Sales at Rs 7.00 crore, up 7973.59% Y-o-Y
12.04.2019
Bharat Immuno Standalone March 2019 Net Sales at Rs 70.61 crore, up 225.66% Y-o-Y
31.01.2019
Bharat Immuno Standalone December 2018 Net Sales at Rs 8.28 crore, up 85.45% Y-o-Y
01.11.2019
Bharat Immuno Standalone September 2019 Net Sales at Rs 8.10 crore, up 73.39% Y-o-Y
02.08.2019
Bharat Immuno Standalone June 2019 Net Sales at Rs 7.00 crore, up 7973.59% Y-o-Y
12.04.2019
Bharat Immuno Standalone March 2019 Net Sales at Rs 70.61 crore, up 225.66% Y-o-Y
31.01.2019
Bharat Immuno Standalone December 2018 Net Sales at Rs 8.28 crore, up 85.45% Y-o-Y
